The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice

Nutrition and Cancer

Volumn 67, Issue 5, 2015, Pages 831-838

  Zeng, Huawei ^a   Wu, Min ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; METHYLSELENIC ACID; ORGANOSELENIUM DERIVATIVE; SELENIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL MODEL; BLOOD; C57BL MOUSE; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG EFFECTS; MALE; METABOLISM; MOUSE; PATHOLOGY; PRECLINICAL STUDY; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CASPASE 3; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG EVALUATION, PRECLINICAL; GLUTATHIONE PEROXIDASE; HETEROGRAFTS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; ORGANOSELENIUM COMPOUNDS; SELENIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84934438814     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1042547     Document Type: Article

References (38)

1. Cruz-Correa M and Giardiello FM: Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am 31, 537-549, 2002.
2. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87, 159-170, 1996.
3. Whanger PD: Selenium and its relationship to cancer: an update. Br J Nutr 91 11-28. 2004
4. Meyer F, Galan P, Douville P, Bairati I, Kegle P, et al.: Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 116, 182-186. 2005.
5. Amaral AF, Cantor KP, Silverman DT, and Malats N: Selenium and Bladder Cancer Risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19, 2407-2415, 2010.
6. Ip C: Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845-1854, 1998.
7. Combs GF Jr: Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135, 343-347, 2005.
8. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963, 1996.
9. Lippman SM, Klein EA, Goodman PJ, Lucia S, Thompson IM, et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39-51, 2009.
10. Rayman MP, Combs GF Jr, and Waters DJ: Selenium and vitamin E supplementation for cancer prevention. JAMA 301, 1876, 2009.
11. L'Abbe MR, Fischer PW, Campbell JS, and Chavez ER: Effects of dietary selenium on DMBA-induced carcinogenesis in rats fed a diet high in mixed fats. J Nutr 119, 757-765, 1989.
12. Ip C and Sinha DK: Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake. Cancer Res 41, 31-34, 1981.
13. Finley JW and Davis CD: Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 14, 191-196, 2001.
14. Lu JC: Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and nonepithelial target cells. Antioxid Redox Signal 7, 1715-1727, 2005.
15. Zeng H and Combs GF Jr: Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19, 1-7, 2008.
16. Li GX, Lee HJ, Wang Z, Hu H, Liao JD, et al.: Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005-1012, 2008.
17. Gunter MJ and Leitzmann MF: Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 17, 145-156, 2006.
18. Jackson MI and Combs GF Jr: Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 11, 718-726, 2008.
19. Rayman MP: Selenium and human health. Lancet 379, 1256-1268, 2012.
20. Rodr?guez-Ruiz J, Belarbi EH, Sanchez JLG, and Alonso DL: Rapid simultaneous lipid extraction and transesterification for fatty acid analyses. Biotechnology Techniques 12, 689-691, 1998.
21. Zhang M, Yao Z, Dubois S, Ju W, Muller JR, et al.: Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A 106, 7513-7518, 2009.
22. Zeng H, Wu M, and Botnen JH: Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellularregulated kinase 1/2 pathway and other cancer signaling genes. J Nutr 139, 1613-1618, 2009.
23. Zeng H, Yan L, Cheng WH, and Uthus EO: Dietary selenomethionine increases exon-specific DNA methylation of the p53 gene in rat liver and colon mucosa. J Nutr 141, 1464-1468, 2011.
24. Yan L Graef GL, Reeves PG, and Johnson LK: Selenium bioavailability from soy protein isolate and tofu in rats fed a torula yeast-based diet. J Agric Food Chem 57, 11575-11580. 2009.
25. Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong ML, et al.: Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol 56, 597-607, 2012.
26. Ip C and Hayes C: Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis 10, 921-925, 1989.
27. Zhuo P and Diamond AM: Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 1790, 1546-1554, 2009.
28. Whanger PD and Butler JA: Effects of various dietary levels of selenium as selenite or selenomethionine on tissue selenium levels and glutathione peroxidase activity in rats. J Nutr 118, 846-852, 1988.
29. Zeng MS, Li X, Liu Y, Zhao H, Zhou JC, et al.: A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic Biol Med 52, 1335-1342, 2012.
30. Prieto-Hontoria PL Perez-Matute P, Fernandez-Galilea M, Bustos MJ, and Moreno-Aliaga MJ: Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta 1807, 664-678 2011.
31. Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919, 2005.
32. Zeng H: Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules 14, 1263-1278, 2009.
33. Zeng H, Briske-Anderson M, Wu M, and Moyer MP: Methylselenol, a selenium metabolite, plays common and different role in cancerous colon HCT116 cell and noncancerous NCM460 colon cell proliferation. Nutr Cancer 64, 128-135, 2012.
34. Li GX, Hu H, Jiang C, Schuster T, and Lu J: Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. Int J Cancer 120, 2034-2043, 2007.
35. Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6, 99-104, 1999.
36. Melis MH, Simpson KL, Dovedi SJ, Welman A, Macfarlane M, et al.: Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ 20, 765-773, 2013.
37. Christensen MJ: Selenium and prostate cancer prevention: what next-if anything? Cancer Prev Res 7, 781-785, 2014.
38. Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, et al.: Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial. Cancer Prev Res 7, 796-804, 2014.